NCT04974398 2025-04-13A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal CarcinomaAkesoPhase 3 Active not recruiting296 enrolled 1 FDA
NCT03866967 2025-02-27A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal CarcinomaAkesoPhase 2 Completed130 enrolled 1 FDA
NCT02915432 2021-12-13The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCCShanghai Junshi Bioscience Co., Ltd.Phase 1/2 Unknown401 enrolled 1 FDA